Acute lymphoblastic leukaemia-type intensive chemotherapy to eliminate minimal residual disease after high-dose melphalan and autologous transplantation in multiple myeloma – a phase I/II feasibility and tolerance study of 17 patients
- 26 April 2000
- journal article
- clinical trial
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 25 (9) , 949-956
- https://doi.org/10.1038/sj.bmt.1702379
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Intensification of treatment for adults with acute lymphoblastic leukaemia: results of U.K. Medical Research Council randomized trial UKALL XABritish Journal of Haematology, 1997
- Comparison of marrow vs blood-derived stem cells for autografting in previously untreated multiple myelomaBritish Journal of Cancer, 1997
- A Prospective, Randomized Trial of Autologous Bone Marrow Transplantation and Chemotherapy in Multiple MyelomaNew England Journal of Medicine, 1996
- Comparison of Interferon Tolerance after Autologous Bone Marrow or Peripheral Blood Stem Cell Transplants for Myeloma Patients who have Responded to Induction TherapyLeukemia & Lymphoma, 1996
- Regulation of initial vinblastine influx by P-glycoproteinBritish Journal of Cancer, 1993
- INTENSIVE TREATMENT OF MULTIPLE MYELOMA AND CRITERIA FOR COMPLETE REMISSIONThe Lancet, 1989
- HIGH-DOSE INTRAVENOUS MELPHALAN FOR PLASMA-CELL LEUKAEMIA AND MYELOMAThe Lancet, 1983
- ANALYSIS OF PROSPECTIVE EPIDEMIOLOGIC STUDIES BY MINIMUM DISTANCE CASE-CONTROL MATCHINGAmerican Journal of Epidemiology, 1977
- A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survivalCancer, 1975
- Use of Ranks in One-Criterion Variance AnalysisJournal of the American Statistical Association, 1952